oral glp 1 agonist for type 2 diabetes In the ACHIEVE-1 phase 3 trial, the small-molecule GLP-1 receptor orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with early Oral Small-Molecule GLP-1 Receptor Agonists:
Description
Kahal H, Abouda G, Rigby AS, et al
& Pittas, A
RinellaMENeuschwander-TetriBASiddiquiMSAbdelmalekMFCaldwellSBarbDet al
Results may vary from person to person
Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent
1921 This has been attributed primarily to increased gastrointestinal oxalate absorption, leading to greater urinary oxalate excretion, 1921 but also to lower citrate excretion and lower urine pH
